{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T03:41:07Z","timestamp":1752550867552,"version":"3.40.5"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Chief Scientist Office of the Scottish Government","award":["ETM\/329","ETM\/145"],"award-info":[{"award-number":["ETM\/329","ETM\/145"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Virological Methods"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.jviromet.2018.10.007","type":"journal-article","created":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T15:50:41Z","timestamp":1540223441000},"page":"55-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Development of an in-house ELISA to detect anti-HPV16-L1 antibodies in serum and dried blood spots"],"prefix":"10.1016","volume":"264","author":[{"given":"Ramya","family":"Bhatia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"June","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon","family":"Moncur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"Cubie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2679-5409","authenticated-orcid":false,"given":"Kimberley","family":"Kavanagh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0635-307X","authenticated-orcid":false,"given":"Kevin G.J.","family":"Pollock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camille","family":"Busby-Earle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7085-4525","authenticated-orcid":false,"given":"Alistair R.W.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7291-3499","authenticated-orcid":false,"given":"Sarah","family":"Howie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate","family":"Cuschieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jviromet.2018.10.007_bib0005","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1128\/CVI.05641-11","article-title":"Human papillomavirus antibody reference reagents for use in postvaccination surveillance serology","volume":"19","author":"Bissett","year":"2012","journal-title":"Clin. Vaccine Immunol. CVI"},{"key":"10.1016\/j.jviromet.2018.10.007_bib0010","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1086\/315498","article-title":"Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection","volume":"181","author":"Carter","year":"2000","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jviromet.2018.10.007_bib0015","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1128\/JCM.01879-06","article-title":"Human immunodeficiency virus (HIV) antibody avidity testing to identify recent infection in newly diagnosed HIV type 1 (HIV-1)-seropositive persons infected with diverse HIV-1 subtypes","volume":"45","author":"Chawla","year":"2007","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jviromet.2018.10.007_bib0020","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1038\/488S2a","article-title":"HPV: the global burden","volume":"488","author":"Crow","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jviromet.2018.10.007_bib0025","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.mcp.2012.01.002","article-title":"Development and application of a GuHCl-modified ELISA to measure the avidity of anti-HPV L1 VLP antibodies in vaccinated individuals","volume":"26","author":"Dauner","year":"2012","journal-title":"Mol. Cell. Probes"},{"key":"10.1016\/j.jviromet.2018.10.007_bib0030","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/infdis\/jir242","article-title":"Serum antibody response following genital {alpha}9 human papillomavirus infection in young men","volume":"204","author":"Edelstein","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jviromet.2018.10.007_bib0035","doi-asserted-by":"crossref","first-page":"6520","DOI":"10.1016\/j.vaccine.2011.07.007","article-title":"The first international standard for antibodies to HPV 16","volume":"29","author":"Ferguson","year":"2011","journal-title":"Vaccine"},{"year":"2012","series-title":"Histopathology Reporting in Cervical Screening: An Integrated Approach","author":"Hirschowitz","key":"10.1016\/j.jviromet.2018.10.007_bib0040"},{"key":"10.1016\/j.jviromet.2018.10.007_bib0045","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1128\/JCM.20.3.525-529.1984","article-title":"Changes in antibody avidity after virus infections: detection by an immunosorbent assay in which a mild protein-denaturing agent is employed","volume":"20","author":"Inouye","year":"1984","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jviromet.2018.10.007_bib0050","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1186\/1471-2334-13-519","article-title":"Estimation of HPV prevalence in young women in Scotland; monitoring of future vaccine impact","volume":"13","author":"Kavanagh","year":"2013","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.jviromet.2018.10.007_bib0055","doi-asserted-by":"crossref","first-page":"e00043","DOI":"10.1128\/mSphere.00043-18","article-title":"Evaluation of dried blood spots and oral fluids as alternatives to serum for human papillomavirus antibody surveillance","volume":"3","author":"Louie","year":"2018","journal-title":"mSphere"},{"key":"10.1016\/j.jviromet.2018.10.007_bib0060","doi-asserted-by":"crossref","first-page":"e0150107","DOI":"10.1371\/journal.pone.0150107","article-title":"HPV serology testing confirms high HPV immunisation coverage in England","volume":"11","author":"Mesher","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jviromet.2018.10.007_bib0065","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/S0140-6736(07)60946-5","article-title":"Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial","volume":"369","author":"Paavonen","year":"2007","journal-title":"Lancet Lond. Engl."},{"issue":"Supplement 3","key":"10.1016\/j.jviromet.2018.10.007_bib0070","first-page":"S193","article-title":"Chapter 23: International Standard reagents for harmonization of HPV serology and DNA assays\u2014an update","volume":"24","author":"Pagliusi","year":"2006","journal-title":"Vaccine, HPV Vaccines Screening Prev. Cervical Cancer"},{"key":"10.1016\/j.jviromet.2018.10.007_bib0075","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jcv.2015.10.023","article-title":"Commercially available molecular tests for human papillomaviruses (HPV): 2015 update","volume":"76","author":"Poljak","year":"2016","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jviromet.2018.10.007_bib0080","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3390\/jcm4020260","article-title":"HPV carcinomas in immunocompromised patients","volume":"4","author":"Reusser","year":"2015","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jviromet.2018.10.007_bib0085","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1470-2045(15)00414-3","article-title":"Immunogenicity and HPV infection after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre prospective cohort study","volume":"17","author":"Sankaranarayanan","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jviromet.2018.10.007_bib0090","doi-asserted-by":"crossref","first-page":"e74797","DOI":"10.1371\/journal.pone.0074797","article-title":"Characteristics of HPV-specific antibody responses induced by infection and vaccination: cross-reactivity, neutralizing activity, avidity and IgG subclasses","volume":"8","author":"Scherpenisse","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jviromet.2018.10.007_bib0095","doi-asserted-by":"crossref","first-page":"16086","DOI":"10.1038\/nrdp.2016.86","article-title":"Carcinogenic human papillomavirus infection","volume":"2","author":"Schiffman","year":"2016","journal-title":"Nat. Rev. Dis. Primer"},{"year":"2013","series-title":"Achievable Standards, Benchmarks for Reporting, and Criteria for Conducting Cervical Cytopathology","author":"Smith","key":"10.1016\/j.jviromet.2018.10.007_bib0100"},{"key":"10.1016\/j.jviromet.2018.10.007_bib0105","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1542\/peds.2014-3745","article-title":"Immunogenicity and safety of a 9-valent HPV vaccine","volume":"136","author":"Van Damme","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.jviromet.2018.10.007_bib0110","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/sj.bjc.6603469","article-title":"High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6\/11\/16\/18 L1 virus-like particle vaccine through 5 years of follow-up","volume":"95","author":"Villa","year":"2006","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jviromet.2018.10.007_bib0115","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1158\/1055-9965.EPI-03-0166","article-title":"Seroreactivity to Human Papillomavirus (HPV) Types 16, 18, or 31 and Risk of Subsequent HPV Infection Results from a Population-Based Study in Costa Rica","volume":"13","author":"Viscidi","year":"2004","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.jviromet.2018.10.007_bib0120","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1158\/1055-9965.EPI-11-1001","article-title":"Dried blood spot samples for seroepidemiology of infections with human papillomaviruses, Helicobacter pylori, Hepatitis C Virus, and JC Virus","volume":"21","author":"Waterboer","year":"2012","journal-title":"Cancer Epidemiol. Biomark. Prev. Publ. Am. Assoc. Cancer Res. Cosponsored Am. Soc. Prev. Oncol."},{"key":"10.1016\/j.jviromet.2018.10.007_bib0125","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1373\/clinchem.2005.052381","article-title":"Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins","volume":"51","author":"Waterboer","year":"2005","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jviromet.2018.10.007_bib0130","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/infdis\/jir209","article-title":"A competitive serological assay shows naturally acquired immunity to human papillomavirus infections in the Guanacaste natural history study","volume":"204","author":"Wentzensen","year":"2011","journal-title":"J. Infect. Dis."}],"container-title":["Journal of Virological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093418303069?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093418303069?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T19:45:20Z","timestamp":1605296720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166093418303069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":26,"alternative-id":["S0166093418303069"],"URL":"https:\/\/doi.org\/10.1016\/j.jviromet.2018.10.007","relation":{},"ISSN":["0166-0934"],"issn-type":[{"type":"print","value":"0166-0934"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of an in-house ELISA to detect anti-HPV16-L1 antibodies in serum and dried blood spots","name":"articletitle","label":"Article Title"},{"value":"Journal of Virological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jviromet.2018.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2018 Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}